share_log

Maxim Group Initiates Coverage On OS Therapies With Buy Rating, Announces Price Target of $8

Maxim Group Initiates Coverage On OS Therapies With Buy Rating, Announces Price Target of $8

Maxim Group發佈買入評級,宣佈將OS Therapies的目標價定爲$8
Benzinga ·  2024/11/26 22:54  · 評級/大行評級

Maxim Group analyst Jason McCarthy initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $8.

Maxim Group分析師Jason McCarthy開始對OS Therapies(美交所:OSTX)進行覆蓋,並給予買入評級,宣佈8美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論